Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 47Terminated 21Active not recruiting 20Recruiting 12Unknown 5Withdrawn 2Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1HTLV-I Infections 1Esophageal Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1Congenital Abnormalities 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

E 7107 2Carboplatin 2palbociclib 1gedatolisib 1eniluracil 1dabrafenib 1abarelix 1Topotecan 1Standard of Care 1Radionuclide Imaging 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Passive Cutaneous Anaphylaxis 1Paclitaxel 1NUC-1031 1Morphine 1Methadone 1Maltose 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1KB004 1Injections 1Infusions, Parenteral 1Hyperthermic Intraperitoneal Chemotherapy 1Hydromorphone 1Gemcitabine 1Fluorodeoxyglucose F18 1Flucytosine 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasms × Cyclophosphamide × Clear all
NCT02354547 2026-05-08

A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors

SynerGene Therapeutics, Inc.

Phase 1 Suspended
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡